Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1959 1
1961 1
1970 1
1975 1
1976 1
1982 2
1983 1
1984 1
1986 1
1991 1
1996 2
1997 10
1998 5
1999 5
2000 12
2001 8
2002 11
2003 12
2004 12
2005 7
2006 16
2007 12
2008 10
2009 17
2010 17
2011 24
2012 26
2013 18
2014 21
2015 22
2016 18
2017 10
2018 21
2019 23
2020 23
2021 38
2022 41
2023 3
Text availability
Article attribute
Article type
Publication date

Search Results

407 results
Results by year
Filters applied: . Clear all
Page 1
Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial.
Kato K, Cho BC, Takahashi M, Okada M, Lin CY, Chin K, Kadowaki S, Ahn MJ, Hamamoto Y, Doki Y, Yen CC, Kubota Y, Kim SB, Hsu CH, Holtved E, Xynos I, Kodani M, Kitagawa Y. Kato K, et al. Among authors: yen cc. Lancet Oncol. 2019 Nov;20(11):1506-1517. doi: 10.1016/S1470-2045(19)30626-6. Epub 2019 Sep 30. Lancet Oncol. 2019. PMID: 31582355 Clinical Trial.
Three-Year Follow-Up and Response-Survival Relationship of Nivolumab in Previously Treated Patients with Advanced Esophageal Squamous Cell Carcinoma (ATTRACTION-3).
Okada M, Kato K, Cho BC, Takahashi M, Lin CY, Chin K, Kadowaki S, Ahn MJ, Hamamoto Y, Doki Y, Yen CC, Kubota Y, Kim SB, Hsu CH, Holtved E, Xynos I, Matsumura Y, Takazawa A, Kitagawa Y. Okada M, et al. Among authors: yen cc. Clin Cancer Res. 2022 Aug 2;28(15):3277-3286. doi: 10.1158/1078-0432.CCR-21-0985. Clin Cancer Res. 2022. PMID: 35294546 Free PMC article.
Effect of Doxorubicin Plus Olaratumab vs Doxorubicin Plus Placebo on Survival in Patients With Advanced Soft Tissue Sarcomas: The ANNOUNCE Randomized Clinical Trial.
Tap WD, Wagner AJ, Schöffski P, Martin-Broto J, Krarup-Hansen A, Ganjoo KN, Yen CC, Abdul Razak AR, Spira A, Kawai A, Le Cesne A, Van Tine BA, Naito Y, Park SH, Fedenko A, Pápai Z, Soldatenkova V, Shahir A, Mo G, Wright J, Jones RL; ANNOUNCE Investigators. Tap WD, et al. Among authors: yen cc. JAMA. 2020 Apr 7;323(13):1266-1276. doi: 10.1001/jama.2020.1707. JAMA. 2020. PMID: 32259228 Free PMC article. Clinical Trial.
Nanocomposite bioinks for 3D bioprinting.
Cai Y, Chang SY, Gan SW, Ma S, Lu WF, Yen CC. Cai Y, et al. Among authors: yen cc. Acta Biomater. 2022 Oct 1;151:45-69. doi: 10.1016/j.actbio.2022.08.014. Epub 2022 Aug 13. Acta Biomater. 2022. PMID: 35970479 Review.
65-year-old woman with hematemesis.
Yen CC, Wang CK. Yen CC, et al. J Am Coll Emerg Physicians Open. 2021 Jul 12;2(4):e12510. doi: 10.1002/emp2.12510. eCollection 2021 Aug. J Am Coll Emerg Physicians Open. 2021. PMID: 34278379 Free PMC article. No abstract available.
Independent finger-mounted device for vein visualization.
Cai EZ, Hon RSM, Chow WT, Yen CC, Lim TC. Cai EZ, et al. Among authors: yen cc. Arch Plast Surg. 2021 May;48(3):336-337. doi: 10.5999/aps.2020.02096. Epub 2021 May 15. Arch Plast Surg. 2021. PMID: 34024080 Free PMC article. No abstract available.
[Theophylline--present concepts].
Cukier A, Terra Filho M, Yen CC, Santos SR, Vargas FS. Cukier A, et al. Among authors: yen cc. Rev Paul Med. 1984 Jan-Feb;102(1):27-30. Rev Paul Med. 1984. PMID: 6740120 Portuguese. No abstract available.
407 results